Ryan J. Watts

President and CEO

Ryan J. Watts (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Denali Therapeutics Inc. (DNLI). The largest single filing was $581K of DNLI (35,198 sh × $16.50, as filed), executed Jan 6.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$581K

shares × price, as filed

Last traded

Jan 6

Filed Jan 8

Median ADV $37.0M across their filed names

Open performance→

Volume by month

Buys $0 Sells $9.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

DNLI Denali Therapeutics Inc. DNLI · 0 buys · 4 sells 4 filings

Recent filings

DNLISALE Denali Therapeutics Inc. View filing → $581K
35,198 sh × $16.50
Exec Jan 6
Filed Jan 8 · 5:30 PM ET DNLISALE Denali Therapeutics Inc. View filing → $7.4M
495,282 sh × $15.00
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET DNLISALE Denali Therapeutics Inc. View filing → $751K
36,916 sh across 2 lots
Exec Jan 6 2025
Filed Jan 8 2025 · 5:30 PM ET DNLISALE Denali Therapeutics Inc. View filing → $1.1M
40,000 sh × $27.69
Exec Oct 18 2024
Filed Oct 22 2024 · 5:30 PM ET